Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice.
about
Antiviral actions of interferonsLiposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferonAlpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.Cytokines in experimental herpes simplex virus infection.Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.Interferon-gamma, macrophages, and virus spread after HSV-1 injection.CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection.Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells.An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3The case for immunomodulatory approaches in treating HSV encephalitis.Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoffProtective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.IFNγ inhibits G-CSF induced neutrophil expansion and invasion of the CNS to prevent viral encephalitis.
P2860
Q24550676-E4DE4ADB-2DB4-4C50-A284-96FDDF28AFFFQ33668447-D022C073-C4D7-48F3-8CD7-E98FAD511A55Q33849352-C89B005E-77CE-4AB3-A976-AA59CF762D4FQ34344812-37372ECE-208E-44AB-AFF0-D0DA91A7151BQ34356255-F322D0A3-6EBE-4477-8545-4ADA5DC268C3Q35027524-4E380885-2FDC-4960-9A20-E26321FA918CQ35168425-82B079DA-7A6D-4A88-86E9-433CD01EDA77Q35220908-E87843FD-9007-471E-A13E-A607D89E0795Q35729193-9CDF837D-1790-45AA-BDE9-EB28BAA6011DQ35947667-52A7AC31-C1D1-4E52-8681-EFF5AA0A4680Q36677447-E54DA566-A392-4276-85AA-8FDDDCEDADAFQ37091308-9BE016BA-E76F-4ECD-91F4-1DD892FBEFC4Q37093565-E579074A-B3B8-4456-8657-243CD817F789Q37967563-AEDAF59C-D3E4-4701-A3F5-538CB97434FAQ38523847-AEF352A8-CC3E-4FB0-97AD-EDAD11982514Q38554939-FD370B7F-E4EA-4126-B114-7A11F28F247EQ39684976-9BDFD967-F38A-4BCB-A1D9-7921F0B87ABAQ47551082-009782CB-9255-4590-AF17-1CE1941AA2FF
P2860
Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Gamma interferon impedes the e ...... nance or reactivation in mice.
@ast
Gamma interferon impedes the e ...... nance or reactivation in mice.
@en
type
label
Gamma interferon impedes the e ...... nance or reactivation in mice.
@ast
Gamma interferon impedes the e ...... nance or reactivation in mice.
@en
prefLabel
Gamma interferon impedes the e ...... nance or reactivation in mice.
@ast
Gamma interferon impedes the e ...... nance or reactivation in mice.
@en
P2093
P2860
P1433
P1476
Gamma interferon impedes the e ...... enance or reactivation in mice
@en
P2093
J A Lekstrom-Himes
L Pesnicak
R A LeBlanc
S E Straus
P2860
P304
P356
10.1128/JVI.74.14.6680-6683.2000
P50
P577
2000-07-01T00:00:00Z